117 related articles for article (PubMed ID: 22509814)
1. Frequency of IL28B rs12979860 single-nucleotide polymorphism alleles in newborn infants and in patients with chronic hepatitis C in Morocco.
Tajir M; Elmachad M; Kabbaj N; Laarabi FZ; Barkat A; Amrani N; Sefiani A
Genet Test Mol Biomarkers; 2012 Aug; 16(8):981-3. PubMed ID: 22509814
[TBL] [Abstract][Full Text] [Related]
2. The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.
Nadia K; Hicham E; Reda TM; Nadia T; Elarbi B; Saâd E; Mimoun Z; Saâd M
Gene; 2015 Aug; 568(1):31-4. PubMed ID: 25958342
[TBL] [Abstract][Full Text] [Related]
3. High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.
Fateh A; Aghasadeghi MR; Keyvani H; Mollaie HR; Yari S; Hadizade Tasbiti AR; Ghazanfari M; Monavari SH
Asian Pac J Cancer Prev; 2015; 16(5):1873-80. PubMed ID: 25773839
[TBL] [Abstract][Full Text] [Related]
4. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
[TBL] [Abstract][Full Text] [Related]
6. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
Sarrazin C; Susser S; Doehring A; Lange CM; Müller T; Schlecker C; Herrmann E; Lötsch J; Berg T
J Hepatol; 2011 Mar; 54(3):415-21. PubMed ID: 21112657
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
[TBL] [Abstract][Full Text] [Related]
8. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
10. [IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].
Pár A; Pár G; Tornai I; Szalay F; Várszegi D; Fráter E; Papp M; Lengyel G; Fehér J; Varga M; Gervain J; Schuller J; Nemes Z; Péterfi Z; Tusnádi A; Hunyady B; Haragh A; Szinku Z; Pálinkás L; Berki T; Vincze A; Kisfali P; Melegh B
Orv Hetil; 2013 Aug; 154(32):1261-8. PubMed ID: 23916907
[TBL] [Abstract][Full Text] [Related]
11. A genetic variant in the interleukin 28B gene as a major predictor for sustained virologic response in chronic hepatitis C virus infection.
Sixtos-Alonso MS; Avalos-Martinez R; Sandoval-Salas R; Dehesa-Violante M; García-Juarez I; Chávez-Ayala A; Domínguez-López A; Vargas-Vorácková F; Toapanta-Yanchapaxi L; Amezcua-Guerra LM; Uribe M; Sánchez-Ávila JF
Arch Med Res; 2015 Aug; 46(6):448-53. PubMed ID: 26189761
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
[TBL] [Abstract][Full Text] [Related]
13. Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.
Ladero JM; Martin EG; Fernández C; Carballo M; Devesa MJ; Martínez C; Suárez A; Díaz-Rubio M; Agúndez JA
J Gastroenterol Hepatol; 2012 Feb; 27(2):279-85. PubMed ID: 21722179
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of interleukin-28B and RNAse L gene polymorphism determination in patients with chronic viral hepatitis C].
Mitsura VM; Voropaev EV; Osipkina OV; Zhavoronok SV; Tereshkov DV; Baranov OIu
Zh Mikrobiol Epidemiol Immunobiol; 2014; (4):30-6. PubMed ID: 25286525
[TBL] [Abstract][Full Text] [Related]
15. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P
Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724
[TBL] [Abstract][Full Text] [Related]
16. Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin.
de Rueda PM; López-Nevot MÁ; Sáenz-López P; Casado J; Martín-Casares A; Palomares P; Quiles R; Gila A; Romero-Gómez M; Pavón EJ; Muñoz JA; Carazo A; Sanz-Cameno P; Moreno-Otero R; Diago M; León J; Ruiz-Extremera A; Salmerón J
Am J Gastroenterol; 2011 Jul; 106(7):1246-54. PubMed ID: 21670772
[TBL] [Abstract][Full Text] [Related]
17. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.
Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171
[TBL] [Abstract][Full Text] [Related]
18. Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.
Murakawa M; Asahina Y; Nakagawa M; Sakamoto N; Nitta S; Kusano-Kitazume A; Watanabe T; Kawai-Kitahata F; Otani S; Taniguchi M; Goto F; Nishimura-Sakurai Y; Itsui Y; Azuma S; Kakinuma S; Watanabe M
J Gastroenterol Hepatol; 2015 Jun; 30(6):1075-84. PubMed ID: 25611696
[TBL] [Abstract][Full Text] [Related]
19. A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
Halfon P; Bourliere M; Ouzan D; Maor Y; Renou C; Wartelle C; Pénaranda G; Tran A; Botta D; Oules V; Castellani P; Portal I; Argiro L; Dessein A
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):931-5. PubMed ID: 21900787
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4.
Rizk NM; Derbala MF
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):262-8. PubMed ID: 23137758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]